Latest Bio-Techne News & Updates

See the latest news and media coverage for Bio-Techne. We track all announcements, press releases, and industry mentions in real time, all in one place.

Bio-Techne

Life sciences tools and services company

bio-techne.com

Headquarters: Minneapolis, United States
Company type: Public company
Number of employees: 3,000–5,000
Industry: Biotechnology & Medical Research

Last updated October 8

Latest news about Bio-Techne

In short: Bio-Techne shareholders approved Merck’s $11.3 billion acquisition as fiscal Q4 revenue rose 1%.

Company announcements

October 8 Bio-Techne

Bio-Techne opens new GMP facility in Bristol, UK

The CEO discussed cell therapy advancements with local leaders. This expansion supports global developers advancing from development to commercialization.

September 23 Bio-Techne

Bio-Techne shareholders approve acquisition by Merck KGaA

Shareholders voted in favor of the merger agreement. The company expects to close the transaction by late 2026 or early 2027.

September 22 Bio-Techne

Bio-Techne opens a new Customer Experience Center in Düsseldorf

The facility supports scientific discovery and collaboration across the DACH and EMEA regions through hands-on technology demonstrations and training.

September 14 Bio-Techne

Bio-Techne supplements merger proxy disclosures amid shareholder litigation

The company voluntarily adds supplemental disclosures to its Proxy Statement regarding the Merck KGaA acquisition to address a filed lawsuit and demand letters from shareholders.

Media coverage

October 6 Ad Hoc News

Bio-Techne approves Merck deal: what it means for Bio-Techne stock

The approval removes one shareholder hurdle, but the transaction still depends on customary closing conditions and remaining regulatory approvals. Bio-Techne expects the deal to close...

September 23 The Globe and Mail

Bio-Techne Shareholders Approve Merck Acquisition Agreement

Bio-Techne ( ) has shared an announcement. On September 23, 2026, Bio-Techne shareholders approved the Agreement and Plan of Merger under which Merck KGaA, Darmstadt...

September 14 Investing.com

Bio-Techne issues supplemental merger disclosures amid shareholder lawsuit By Investing.com

Bio-Techne Corporation (NASDAQ:TECH) on Monday released supplemental disclosures related to its pending merger with Merck KGaA, Darmstadt, Germany, following a shareholder lawsuit and the receipt...

September 7 WOWK-TV

Are FULC, WEAV, TECH Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders....

Never miss news about Bio-Techne

Track Bio-Techne and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Bio-Techne competitors & trending companies

Browse news for competitors to Bio-Techne and other trending companies.